INTRODUCTION: The EORTC QLQ-INFO25 evaluates the information received by cancer patients. This study assesses the psychometric properties of the QLQ-INFO25 when applied to a sample of Spanish patients. MATERIALS AND METHODS: A total of 169 patients with different cancers and stages of disease completed the EORTC QLQINFO25, the EORTC QLQ-C30 and the information scales of the inpatient satisfaction module EORTC IN-PATSAT32 on two occasions during the patients' treatment and follow- up period. Psychometric evaluation of the structure, reliability, validity and responsiveness to changes was conducted. Patient acceptability was assessed with a debriefing questionnaire. RESULTS: Multi-trait scaling confirmed the 4 multi-item scales (information about disease, medical tests, treatment and other services) and eight single items. All items met the standards for convergent validity and all except one met the standards of item discriminant validity. Internal consistency for all scales (α>0.70) and the whole questionnaire (α>0.90) was adequate in the three measurements, except information about the disease (0.67) and other services (0.68) in the first measurement, as was test-retest reliability (intraclass correlations >0.70). Correlations with related areas of IN-PATSAT32 (r>0.40) supported convergent validity. Divergent validity was confirmed through low correlations with EORTC QLQ-C30 scales (r<0.30). The EORTC QLQ-INFO-25 discriminated among groups based on gender, age, education, levels of anxiety and depression, treatment line, wish for information and satisfaction. One scale and an item showed changes over time. CONCLUSIONS: The EORTC QLQ-INFO 25 is a reliable and valid instrument when applied to a sample of Spanish cancer patients. These results are in line with those of the EORTC validation study.
INTRODUCTION: The EORTC QLQ-INFO25 evaluates the information received by cancerpatients. This study assesses the psychometric properties of the QLQ-INFO25 when applied to a sample of Spanish patients. MATERIALS AND METHODS: A total of 169 patients with different cancers and stages of disease completed the EORTC QLQINFO25, the EORTC QLQ-C30 and the information scales of the inpatient satisfaction module EORTC IN-PATSAT32 on two occasions during the patients' treatment and follow- up period. Psychometric evaluation of the structure, reliability, validity and responsiveness to changes was conducted. Patient acceptability was assessed with a debriefing questionnaire. RESULTS: Multi-trait scaling confirmed the 4 multi-item scales (information about disease, medical tests, treatment and other services) and eight single items. All items met the standards for convergent validity and all except one met the standards of item discriminant validity. Internal consistency for all scales (α>0.70) and the whole questionnaire (α>0.90) was adequate in the three measurements, except information about the disease (0.67) and other services (0.68) in the first measurement, as was test-retest reliability (intraclass correlations >0.70). Correlations with related areas of IN-PATSAT32 (r>0.40) supported convergent validity. Divergent validity was confirmed through low correlations with EORTC QLQ-C30 scales (r<0.30). The EORTC QLQ-INFO-25 discriminated among groups based on gender, age, education, levels of anxiety and depression, treatment line, wish for information and satisfaction. One scale and an item showed changes over time. CONCLUSIONS: The EORTC QLQ-INFO 25 is a reliable and valid instrument when applied to a sample of Spanish cancerpatients. These results are in line with those of the EORTC validation study.
Authors: Juan Ignacio Arraras; Eva Greimel; Orhan Sezer; Wei-Chu Chie; Mia Bergenmar; Anna Costantini; Teresa Young; Karin Kuljanic Vlasic; Galina Velikova Journal: Eur J Cancer Date: 2010-07-30 Impact factor: 9.162
Authors: S Galloway; J Graydon; D Harrison; B Evans-Boyden; S Palmer-Wickham; S Burlein-Hall; L Rich-van der Bij; P West; A Blair Journal: J Adv Nurs Date: 1997-06 Impact factor: 3.187
Authors: Elsbeth Voogt; Anna F van Leeuwen; Adriaan P Visser; Agnes van der Heide; Paul J van der Maas Journal: Support Care Cancer Date: 2005-04-27 Impact factor: 3.603
Authors: Mir Saeed Yekaninejad; Amir H Pakpour; Jyothi Tadakamadla; Santhosh Kumar; Seyed Hamzeh Mosavi; Bengt Fridlund; Andrew Bottomley; Neil K Aaronson Journal: Support Care Cancer Date: 2014-10-15 Impact factor: 3.603
Authors: Mirosława Püsküllüoğlu; Krzysztof A Tomaszewski; Aneta L Zygulska; Sebastian Ochenduszko; Joanna Streb; Iwona M Tomaszewska; Krzysztof Krzemieniecki Journal: Appl Res Qual Life Date: 2013-06-28